Drugmaker Bristol-Myers Squibb Co. on Thursday reported double-digit jumps in first-quarter sales and net income, beating Wall Street expectations, but it lowered its 2010 profit forecast by a nickel due to the impact of the health care overhaul.
April 29, 2010 at 02:23 PM
1 minute read
Drugmaker Bristol-Myers Squibb Co. on Thursday reported double-digit jumps in first-quarter sales and net income, beating Wall Street expectations, but it lowered its 2010 profit forecast by a nickel due to the impact of the health care overhaul.
Still, the maker of blockbuster blood thinner Plavix posted a very healthy improvement in first-quarter profit, which jumped 16.5 percent to $743 million, or 43 cents per share, from $638 million or 32 cents per share, in the first quarter of 2009.
Presented by BigVoodoo
The Legal Intelligencer honors lawyers leaving a mark on the legal community in Pennsylvania and Delaware.
Consulting Magazine recognizes leaders in technology across three categories Leadership, Client Service and Innovation.
Celebrate outstanding achievement in law firms, chambers, in-house legal departments and alternative business structures.
We are seeking an associate to join our Employee Benefits practice. Candidates should have three to six years of employee benefits experienc...
Health Law Associate CT Shipman is seeking an associate to join our national longstanding health law practice. Candidates must have t...
Shipman & Goodwin LLP is seeking two associates to expand our national commercial real estate lending practice. Candidates should have ...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS
